In a patient who cannot provide a 24‑hour urine sample, cannot undergo a salivary cortisol test, and cannot have a blood draw at 8 am but can have an earlier blood draw, what is the optimal screening test for hypercortisolism?

Overnight 1-mg Dexamethasone Suppression Test (DST)

In a patient who cannot provide urine, cannot do salivary testing, and cannot have an 8 am blood draw but can have an earlier blood draw, the overnight 1-mg dexamethasone suppression test (DST) is the best screening test for hypercortisolism.

Rationale for This Recommendation

The 1-mg DST is specifically designed to accommodate your patient's constraints:

• Does not require urine collection - eliminating the 24-hour UFC option 1
• Does not require salivary collection - eliminating late-night salivary cortisol 1
• Blood draw timing is flexible - the patient takes 1 mg dexamethasone between 11 PM-midnight, and blood can be drawn the following morning at whatever time is feasible (typically 8-9 AM, but earlier draws are acceptable) 2

Test Performance Characteristics

The 1-mg DST has excellent diagnostic accuracy according to the 2021 Lancet Diabetes & Endocrinology consensus guidelines 1:

• Sensitivity: >90% (among the highest of all screening tests)
• Specificity: Lower than LNSC but still clinically useful
• Practical advantages: Simple, outpatient-based, inexpensive, widely available 2

How to Perform the Test

1. Administration: Give 1 mg dexamethasone orally between 11 PM and midnight
2. Blood draw: Obtain serum cortisol the following morning (standard is 8-9 AM, but earlier is acceptable if necessary)
3. Interpretation:
   • Cortisol <1.8 μg/dL (50 nmol/L) = normal response, excludes hypercortisolism 1
   • Cortisol >5 μg/dL (138 nmol/L) = strongly suggests hypercortisolism 1
   • Values between 1.8-5 μg/dL = indeterminate, requires additional testing

Critical Pitfalls to Avoid

Measure Dexamethasone Level Simultaneously

Always measure dexamethasone level with the cortisol to reduce false-positive results 1. A dexamethasone level ≥140 ng/dL confirms adequate absorption and compliance.

Drug Interactions

False-positive results (inadequate suppression) can occur with:

• CYP3A4 inducers: phenobarbital, carbamazepine, phenytoin, rifampin, St. John's wort 1
• Increased CBG states: oral estrogens, pregnancy, chronic active hepatitis 1
• Malabsorption conditions: celiac disease, chronic diarrhea 1

False-negative results (excessive suppression) can occur with:

• CYP3A4 inhibitors: fluoxetine, cimetidine, diltiazem 1
• Decreased CBG/albumin: nephrotic syndrome 1

Special Populations

The 2008 Endocrine Society guidelines specifically recommend:

• Renal failure: Use 1-mg DST rather than UFC 2
• Adrenal incidentaloma: Use 1-mg DST or late-night cortisol rather than UFC 2
• Avoid in pregnancy: Dexamethasone testing has increased false-positives; UFC is preferred 2
• Avoid with antiepileptic drugs: Use non-suppressed cortisol measurements instead 2

Why Not Other Tests?

• 24-hour UFC: Patient cannot provide urine (explicitly excluded) 1
• Late-night salivary cortisol: Patient cannot provide saliva (explicitly excluded) 1
• 8 AM cortisol alone: Not a screening test for hypercortisolism; requires assessment of circadian rhythm loss or suppression testing
• Midnight serum cortisol: Requires hospitalization for 48+ hours and blood draw at midnight while sleeping - impractical and not recommended for initial screening 2

Confirmation Strategy

If the DST is abnormal, the 2021 consensus guidelines recommend 1:

• Refer to endocrinology
• Perform a second different test to confirm (though options are limited in your patient)
• Consider dexamethasone-CRH test as a confirmatory option if available

The 1-mg DST remains the most practical and guideline-supported option for your specific clinical scenario where standard screening tests are not feasible 1, 2.